enVVeno Medical Corporation (NVNO)
USD 2.48
(-4.25%)
USD 2.48
(-4.25%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -25.23 Million USD | -1.23% |
| 2022 | -24.93 Million USD | -47.59% |
| 2021 | -16.89 Million USD | -84.92% |
| 2020 | -9.13 Million USD | -19.02% |
| 2019 | -7.67 Million USD | 2.28% |
| 2018 | -7.85 Million USD | -28.7% |
| 2017 | -6.1 Million USD | -30.99% |
| 2016 | -4.65 Million USD | -261.22% |
| 2015 | -1.28 Million USD | -35.39% |
| 2014 | -952.65 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -5.45 Million USD | 0.89% |
| 2024 Q1 | -5.5 Million USD | 12.34% |
| 2024 Q3 | -6.17 Million USD | -13.13% |
| 2023 Q2 | -6.81 Million USD | -0.25% |
| 2023 FY | -25.23 Million USD | -1.23% |
| 2023 Q1 | -6.79 Million USD | -5.22% |
| 2023 Q3 | -5.34 Million USD | 21.5% |
| 2023 Q4 | -6.27 Million USD | -17.37% |
| 2022 Q1 | -5.33 Million USD | 40.67% |
| 2022 FY | -24.93 Million USD | -47.59% |
| 2022 Q4 | -6.46 Million USD | -5.02% |
| 2022 Q3 | -6.15 Million USD | 11.95% |
| 2022 Q2 | -6.98 Million USD | -30.95% |
| 2021 FY | -16.89 Million USD | -84.92% |
| 2021 Q3 | -2.7 Million USD | -13.46% |
| 2021 Q2 | -2.38 Million USD | 15.06% |
| 2021 Q1 | -2.8 Million USD | 32.47% |
| 2021 Q4 | -8.99 Million USD | -232.24% |
| 2020 Q2 | -1.54 Million USD | -2.48% |
| 2020 Q4 | -4.15 Million USD | -116.33% |
| 2020 FY | -9.13 Million USD | -19.02% |
| 2020 Q1 | -1.5 Million USD | 34.38% |
| 2020 Q3 | -1.92 Million USD | -24.35% |
| 2019 Q4 | -2.29 Million USD | -25.35% |
| 2019 FY | -7.67 Million USD | 2.28% |
| 2019 Q3 | -1.83 Million USD | 6.42% |
| 2019 Q2 | -1.95 Million USD | -23.86% |
| 2019 Q1 | -1.58 Million USD | 12.04% |
| 2018 Q3 | -1.48 Million USD | 52.19% |
| 2018 Q4 | -1.79 Million USD | -20.92% |
| 2018 FY | -7.85 Million USD | -28.7% |
| 2018 Q1 | -1.45 Million USD | 24.49% |
| 2018 Q2 | -3.11 Million USD | -113.66% |
| 2017 Q3 | -1.81 Million USD | -47.12% |
| 2017 FY | -6.1 Million USD | -30.99% |
| 2017 Q1 | -1.13 Million USD | 0.44% |
| 2017 Q2 | -1.23 Million USD | -8.94% |
| 2017 Q4 | -1.92 Million USD | -6.43% |
| 2016 Q2 | -1.23 Million USD | 0.0% |
| 2016 Q3 | -1.06 Million USD | 13.91% |
| 2016 Q1 | -1.23 Million USD | -111.08% |
| 2016 Q4 | -1.13 Million USD | -7.1% |
| 2016 FY | -4.65 Million USD | -261.22% |
| 2015 Q4 | -583.5 Thousand USD | 0.0% |
| 2015 FY | -1.28 Million USD | -35.39% |
| 2014 FY | -952.65 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -75.74% |
| Cerus Corporation | -30.05 Million USD | 16.022% |
| OrthoPediatrics Corp. | -25.76 Million USD | 2.049% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -137.616% |
| Talis Biomedical Corporation | -66.81 Million USD | 62.227% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -45.918% |
| Inogen, Inc. | -109.38 Million USD | 76.928% |
| Spectral AI, Inc. | -12.98 Million USD | -94.378% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 59.677% |
| CVRx, Inc. | -43.1 Million USD | 41.447% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -615.363% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -103.074% |
| Orthofix Medical Inc. | -139.11 Million USD | 81.858% |
| Venus Concept Inc. | -28.3 Million USD | 10.848% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 53.287% |
| Bioventus Inc. | -81.72 Million USD | 69.118% |
| BrainsWay Ltd. | -4.92 Million USD | -412.239% |
| Envoy Medical, Inc. | -18.37 Million USD | -37.38% |
| electroCore, Inc. | -18.8 Million USD | -34.209% |
| IceCure Medical Ltd | -15.57 Million USD | -62.031% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 47.944% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -46.154% |
| MaxCyte, Inc. | -48.29 Million USD | 47.746% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -111.104% |
| Nexalin Technology, Inc. | -5.69 Million USD | -343.06% |
| PAVmed Inc | -68.79 Million USD | 63.314% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 55.381% |
| RxSight, Inc. | -50.08 Million USD | 49.61% |
| Sight Sciences, Inc. | -57.27 Million USD | 55.935% |
| SI-BONE, Inc. | -46.93 Million USD | 46.223% |
| TELA Bio, Inc. | -44.07 Million USD | 42.739% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 53.392% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 50.926% |
| LivaNova PLC | -68.49 Million USD | 63.155% |
| 908 Devices Inc. | -42.75 Million USD | 40.975% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 85.445% |
| Nemaura Medical Inc. | -9.59 Million USD | -163.026% |
| NeuroPace, Inc. | -27.17 Million USD | 7.124% |
| LENSAR, Inc. | -12.22 Million USD | -106.378% |
| Apyx Medical Corporation | -17.25 Million USD | -46.231% |
| Cutera, Inc. | -156.23 Million USD | 83.846% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -193.329% |
| BioSig Technologies, Inc. | -28.51 Million USD | 11.483% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 71.202% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -12.439% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 122.63% |
| Axonics, Inc. | -26.05 Million USD | 3.143% |
| Outset Medical, Inc. | -169.77 Million USD | 85.134% |
| IRIDEX Corporation | -10 Million USD | -152.203% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 76.882% |
| IRadimed Corporation | 20.03 Million USD | 225.967% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -206.101% |
| INVO Bioscience, Inc. | -6.76 Million USD | -272.948% |
| Telesis Bio, Inc. | -35.15 Million USD | 28.199% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 276.12% |
| Varex Imaging Corporation | 32.1 Million USD | 178.623% |
| Quipt Home Medical Corp. | 3.91 Million USD | 743.991% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -108.011% |
| Pulmonx Corporation | -61.93 Million USD | 59.251% |
| Dynatronics Corporation | -2.27 Million USD | -1010.315% |
| Modular Medical, Inc. | -17.52 Million USD | -43.979% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -72.402% |
| Semler Scientific, Inc. | 22.25 Million USD | 213.399% |
| InMode Ltd. | 195.66 Million USD | 112.899% |
| Bruker Corporation | 436.9 Million USD | 105.777% |
| Cytosorbents Corporation | -31.2 Million USD | 19.133% |
| DexCom, Inc. | 597.7 Million USD | 104.223% |
| Align Technology, Inc. | 643.33 Million USD | 103.923% |
| Viveve Medical, Inc. | -21.55 Million USD | -17.097% |
| ZimVie Inc. | -30.93 Million USD | 18.427% |
| Movano Inc. | -29.69 Million USD | 14.995% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 9.363% |
| Nexalin Technology, Inc. | -5.69 Million USD | -343.06% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -615.363% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 89.179% |
| Profound Medical Corp. | -28.61 Million USD | 11.805% |
| Insulet Corporation | 220 Million USD | 111.472% |
| Surmodics, Inc. | -5.64 Million USD | -347.086% |
| iCAD, Inc. | -7.68 Million USD | -228.235% |
| Nuwellis, Inc. | -17.63 Million USD | -43.154% |
| Biotricity, Inc. | -8.82 Million USD | -185.877% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 79.836% |
| Aethlon Medical, Inc. | -12.63 Million USD | -99.722% |
| InspireMD, Inc. | -21.14 Million USD | -19.368% |
| PAVmed Inc. | -68.79 Million USD | 63.314% |
| BIOLASE, Inc. | -17.93 Million USD | -40.704% |
| Beyond Air, Inc. | -63 Million USD | 59.943% |
| FONAR Corporation | 16.53 Million USD | 252.63% |
| AxoGen, Inc. | -21.46 Million USD | -17.594% |
| Vivani Medical, Inc. | -26.96 Million USD | 6.405% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 239.892% |
| Inari Medical, Inc. | -14.03 Million USD | -79.86% |
| UFP Technologies, Inc. | 57.66 Million USD | 143.767% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -412.176% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -300.237% |
| Tenon Medical, Inc. | -15.72 Million USD | -60.476% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -237.677% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 40.903% |
| AdaptHealth Corp. | -598.4 Million USD | 95.782% |
| Sintx Technologies, Inc. | -13.35 Million USD | -88.935% |
| NanoVibronix, Inc. | -3.43 Million USD | -634.517% |
| Quanterix Corporation | -49.7 Million USD | 49.22% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -108.011% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -6506.806% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 92.454% |
| TransMedics Group, Inc. | -28.72 Million USD | 12.145% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -6.886% |
| NeuroMetrix, Inc. | -7.15 Million USD | -252.904% |
| Hyperfine, Inc. | -48.11 Million USD | 47.547% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 61.188% |
| Biomerica, Inc. | -6.36 Million USD | -296.388% |
| Bone Biologics Corporation | -9.42 Million USD | -167.683% |
| AVITA Medical, Inc. | -40.4 Million USD | 37.533% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -144.763% |
| Silk Road Medical, Inc | -59.27 Million USD | 57.419% |